Dr. Oz jumps in after man collapses during Oval Office press conference
A drug executive collapsed in the Oval Office while President Donald Trump was announcing a deal with drugmakers to reduce prices. Here's what we know.
Planned Parenthood Medicaid funding cuts hearing today
The legal fight continues Wednesday over the Medicaid funding cuts to Planned Parenthood, which was targeted in President Trump’s tax and spending cut bill this summer.
Menopause hormone therapy labeling changed under FDA
The FDA is lifting a serious “black box" warning from hormone therapies that are used for menopause symptoms.
FDA to address hormone therapy drug label concerns
The FDA says warning labels on some hormone therapy drugs have deterred women who might benefit from receiving menopause treatment. Now, the agency is taking steps it says will make the medicines more accessible. FOX News reporter Mike Emanuel has more.
Voters pass Prop 409, granting Valleywise Health $900M
The campaign for Prop 409 declared victory, securing nearly $900 million for Valleywise Health to build a new mental health hospital. The funding for the proposition will come from property taxes.
Attorney claims medication mix-up led to patient's death
The family of a Valley man who died while being treated for depression at a Gilbert mental health facility has filed a lawsuit alleging he was given the wrong medication. FOX 10's Christina Carilla has the details.
Lawsuit claims medication error killed patient at Gilbert facility
The family of Kyle Slade, a 40-year-old father of four who entered Copper Springs East for depression, has filed a lawsuit claiming his death was caused by a nurse mistakenly administering a fatal overdose of 90 milligrams of methadone.
Trump announces price cuts on Wegovy, Zepbound
President Donald Trump has unveiled a deal with drugmakers Eli Lilly and Novo Nordisk to reduce prices for their obesity treatments Zepbound and Wegovy. Here’s what we know.
Trump '60 Minutes' interview: Here's what happened
Trump returned to “60 Minutes” for the first time after settling a lawsuit against the newsmagazine. Here's what he said on some topics, from testing nuclear weapons to grocery prices.
FDA puts restrictions on fluoride use for kids
Health Secretary Robert F. Kennedy Jr.’s latest action takes aim at fluoride, a chemical that is a mainstay of dental care.
Open enrollment for Affordable Care Act plans begins today
The Health Insurance Marketplace open enrollment period for Obamacare, also known as the Affordable Care Act (ACA), for the 2026 plan year begins on Saturday.
Eli Lilly partners with Walmart to sell weight loss drug directly to patients nationwide
Access for Zepbound through the partnership begins in mid-November.
ARISE Veterinary Center highlights need for pet blood donations
While the need for human blood donations is widely known, pets also rely on the generosity of animal donors to receive life-saving care. FOX 10's Dominique Newland has more from ARISE Veterinary Center.
Phoenix woman's years-long battle with breast cancer: 'Determined to Live'
Robin Chesbro, a Valley mother and grandmother, survived three separate breast cancer diagnoses over three decades, sharing her story of determination to emphasize the importance of vigilance and hope.
Arizona woman beats breast cancer three times
For Valley mother and grandmother Robin Chesbro, the statistic that nearly 1 in 8 women will receive a breast cancer diagnosis became a triple reality over three decades. FOX 10's Kenzie Beach has more on her story.
Most Americans worry about higher health care costs in 2026, poll finds
The prospect of paying more for health care coverage has people who either are insured or not worried about covering their medical needs.
North Dakota ban on gender-affirming care for children upheld by judge
North Dakota's ban on gender-affirming care for children was upheld by a judge on Wednesday.
All Rite Aid locations closed after bankruptcy filing
A pharmacy staple in America is officially no more.
RFK Jr. launches FDA safety review of abortion pill mifepristone
The Food and Drug Administration will review the safety of mifepristone, the most widely used abortion drug in the U.S, at the request of Republican-led states.
ASU Biodesign Institute's research could lead to earlier breast cancer detection
A team at ASU's Biodesign Institute is conducting research to find new ways to detect & treat breast cancer, with a focus on blood-based biomarkers for early detection and a particularly difficult form of the disease called triple-negative breast cancer.